IL1B and cryopyrin-associated periodic syndrome: Indeed, mononuclear cells from CAPS patients spontaneously secrete IL-1β and IL-18 [12], and IL-1 receptor antagonists have proved to be an effective treatment for these autoinflammatory syndromes [27].